Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli
Nathália Abichabki, Luísa Vieira Zacharias, Natália Columbaro Moreira, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria
Ronit Vogt Sionov, Doron Steinberg
Microorganisms (2022) Vol. 10, Iss. 6, pp. 1239-1239
Open Access | Times Cited: 108
Drug Repurposing Against Antibiotic Resistant Bacterial Pathogens
Manya Aggarwal, Anushree Patra, Ishita Awasthi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116833-116833
Closed Access | Times Cited: 8
Cannabidiol (CBD) Acts as an Antioxidant on Gardnerella vaginalis, Resulting in Reduced Metabolic Activity, Loss of Survivability, and Elimination of Biofilms
Ronit Vogt Sionov, Maya Korem, Itzhack Polacheck, et al.
Antibiotics (2025) Vol. 14, Iss. 2, pp. 136-136
Open Access | Times Cited: 1
A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders
Oluwadara Pelumi Omotayo, Yolandy Lemmer, Shayne Mason
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 6
Supercritical fluid extraction of cannabinoids and their analysis by liquid chromatography and supercritical fluid chromatography: A short review
Matjaž Rantaša, Gal Slaček, Željko Knez, et al.
Journal of CO2 Utilization (2024) Vol. 86, pp. 102907-102907
Open Access | Times Cited: 6
Skin applications of cannabidiol: sources, effects, delivery systems, marketed formulations and safety
Beatriz Pires Ferreira, Gustavo Costa, Filipa Mascarenhas‐Melo, et al.
Phytochemistry Reviews (2023) Vol. 22, Iss. 3, pp. 781-828
Open Access | Times Cited: 16
Biosynthesis of Phytocannabinoids and Structural Insights: A Review
Rasiravathanahalli Kaveriyappan Govindarajan, Awdhesh Kumar Mishra, Kiu-Hyung Cho, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 442-442
Open Access | Times Cited: 16
Improved Anti-Biofilm Effect against the Oral Cariogenic Streptococcus mutans by Combined Triclosan/CBD Treatment
Maayan Avraham, Doron Steinberg, Tamar Barak, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 521-521
Open Access | Times Cited: 13
Mechanisms Underlying Synergistic Killing of Polymyxin B in Combination with Cannabidiol against Acinetobacter baumannii: A Metabolomic Study
Maytham Hussein, Rafah Allobawi, Irini Levou, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 786-786
Open Access | Times Cited: 19
Antimicrobial Potential of Cannabinoids: A Scoping Review of the Past 5 Years
Maria João Coelho, Maria Araújo, Márcia Carvalho, et al.
Microorganisms (2025) Vol. 13, Iss. 2, pp. 325-325
Open Access
Anti-Infective Screening of Selected Nine Cannabinoids Against Clostridium perfringens and Influenza A (H5N1) Neuraminidases, and SARS-CoV-2 Main Protease and Spike Protein Interactions
Thanet Pitakbut, Oliver Kayser
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 185-185
Open Access
Drug Repurposing Approaches towards Defeating Multidrug-Resistant Gram-Negative Pathogens: Novel Polymyxin/Non-Antibiotic Combinations
Augustine Jing Jie Koh, Maytham Hussein, Gauri G. Rao, et al.
Pathogens (2022) Vol. 11, Iss. 12, pp. 1420-1420
Open Access | Times Cited: 18
CBD resistant Salmonella strains are susceptible to epsilon 34 phage tailspike protein
Iddrisu Ibrahim, Joseph Ayariga, Junhuan Xu, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 10
Archaeosomes facilitate storage and oral delivery of cannabidiol
Viktor Laurin Sedlmayr, Christina Horn, David Johannes Wurm, et al.
International Journal of Pharmaceutics (2023) Vol. 645, pp. 123434-123434
Open Access | Times Cited: 10
Antimicrobial Effect of Cannabidiol on Intracellular Mycobacterium tuberculosis
Camila Martinena, Merlina Corleto, Melina Martínez, et al.
Cannabis and Cannabinoid Research (2024) Vol. 9, Iss. 2, pp. 464-469
Closed Access | Times Cited: 3
Cannabinoids from C. sativa L.: Systematic Review on Potential Pharmacological Effects against Infectious Diseases Downstream and Multidrug-Resistant Pathogens
Adriana Ribeiro, Rahaf Alsayyed, Daniele Martins de Lima Oliveira, et al.
Future Pharmacology (2024) Vol. 4, Iss. 3, pp. 590-625
Open Access | Times Cited: 3
The Antimicrobial Properties of Cannabis and Cannabis-Derived Compounds and Relevance to CB2-Targeted Neurodegenerative Therapeutics
HeeJue Hong, Lucy Sloan, Deepak Saxena, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1959-1959
Open Access | Times Cited: 12
Cannabis sativa CBD Extract Exhibits Synergy with Broad-Spectrum Antibiotics against Salmonella enterica subsp. Enterica serovar typhimurium
Logan Gildea, Joseph Ayariga, Junhuan Xu, et al.
Microorganisms (2022) Vol. 10, Iss. 12, pp. 2360-2360
Open Access | Times Cited: 10
Discovery of novel cannabidiol derivatives with augmented antibacterial agents against methicillin-resistant Staphylococcus aureus
Zhen Zhang, Zhujun Luo, Sun Ying, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106911-106911
Closed Access | Times Cited: 6
Exploring the versatile roles of the endocannabinoid system and phytocannabinoids in modulating bacterial infections
Hailey Barker, Mariola J. Ferraro
Infection and Immunity (2024) Vol. 92, Iss. 6
Open Access | Times Cited: 1
A comprehensive update on cannabidiol, its formulations and drug delivery systems
Surojit Banerjee, Vikas Anand Saharan, Debadri Banerjee, et al.
Phytochemistry Reviews (2024)
Closed Access | Times Cited: 1
Cannabinoids in Integumentary Wound Care: A Systematic Review of Emerging Preclinical and Clinical Evidence
Dhakshila Niyangoda, Mohammed Muayad, Wubshet Tesfaye, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1081-1081
Open Access | Times Cited: 1
In Vitro Synergistic Activity of Rifampicin Combined with Minimal Effective Antibiotic Concentration (MEAC) of Polymyxin B Against Extensively Drug-Resistant, Carbapenem-, and Polymyxin B-Resistant Klebsiella pneumoniae Clinical Isolates
Nathália Abichabki, Gilberto Gambero Gaspar, Luísa Vieira Zacharias, et al.
Current Microbiology (2024) Vol. 81, Iss. 11
Closed Access | Times Cited: 1
Cannabinoids as Antibacterial Agents: A Systematic and Critical Review of In Vitro Efficacy Against Streptococcus and Staphylococcus
Dhakshila Niyangoda, Myat Lin Aung, Mallique Qader, et al.
Antibiotics (2024) Vol. 13, Iss. 11, pp. 1023-1023
Open Access | Times Cited: 1
<em>Cannabis sativa</em> CBD Extract Exhibits Synergy with Broad-Spectrum Antibiotics against <em>Salmonella typhimurium</em>
Logan Gildea, Joseph Ayariga, Junhuan Xu, et al.
(2022)
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top